Kefir Versus Milk on Time-Trial Performance in Masters Athletes

NCT ID: NCT06165523

Last Updated: 2023-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-07

Study Completion Date

2023-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effects of added probiotic cultures to a carbohydrate + protein recovery beverage compared to a similar recovery beverage without probiotic cultures, in its ability to impact endurance performance, perceived ratings of gastrointestinal symptoms and markers of inflammation and intestinal damage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In a randomized, crossover fashion, the investigators will assess changes in exercise performance, gastrointestinal symptom rating scale scores, as well as interleukin-6 and intestinal fatty-acid binding protein levels following consumption of either water, kefir or flavored milk.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Complication Exercise Performance Aerobic Endurance

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Kefir Milk Aerobic Endurance Exercise Performance Gastrointestinal Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomized, crossover.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Both participant and investigator are unmasked to treatment conditions

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Water

Water

Group Type PLACEBO_COMPARATOR

Water

Intervention Type OTHER

340 mL plain tap water consumed immediately following glycogen depleting exercise

Flavored Kefir

1% Lowfat Kefir manufactured by Lifeway Kefir and containing 18 g of CHO, 10 g of protein, and 2 g of fat

Group Type EXPERIMENTAL

Flavored Kefir

Intervention Type OTHER

320 mL kefir consumed immediately following glycogen depleting exercise

Flavored Milk

1% Lowfat Milk manufactured by Prairie Farms and containing 24 g of CHO, 8 g of protein, and 2.5 g of fat

Group Type ACTIVE_COMPARATOR

Flavored Milk

Intervention Type OTHER

240 mL flavored milk consumed immediately following glycogen depleting exercise

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Water

340 mL plain tap water consumed immediately following glycogen depleting exercise

Intervention Type OTHER

Flavored Kefir

320 mL kefir consumed immediately following glycogen depleting exercise

Intervention Type OTHER

Flavored Milk

240 mL flavored milk consumed immediately following glycogen depleting exercise

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provide voluntary signed and dated informed consent.
* Be in good health as determined by medical history and routine blood chemistries.
* Normotensive (seated, resting systolic blood pressure \< 140 mm Hg and diastolic blood pressure \< 90 mm Hg. If the first measurement is slightly elevated above these limits, the subject will be given a brief (5 minute) rest period, and two more measurements will be taken. The average of all three measurements will be used to determine eligibility.
* Normal seated, resting heart rate (\< 90 beats per minute).
* Age between 40 and 75 years of age
* Body Mass Index \<30 kg/m2 or Body Fat \<30% for females and \<25% for males
* Performing aerobic exercise \> 150 mins/week and training for at least 3 years
* Well-trained will be defined as athletes that meet two of the four following criteria: training frequency is 3-7 sessions/week; duration of training sessions is 60-240 min; training background is at least 3 y; race frequency is at least once a year.

Exclusion Criteria

* Individuals currently diagnosed or being treated for any cardiac, respiratory, endocrine, psychiatric, musculoskeletal, renal, hepatic, neuromuscular or metabolic disease or disorder that in the judgement of the study participant's personal physician or research nurse that will preclude their safe participation or will contraindicate quality control over the collected data
* Individuals currently diagnosed with or are being treated for celiac disease, lactose intolerance, digestive insufficiencies or other gastrointestinal complications such as irritable bowel syndrome, ulcerative colitis, etc.

Alcohol consumption (more than 2 standard alcoholic drinks per day or more than 10 drinks per week) or drug abuse or dependence.

* Smokers or individuals who have quit smoking within the last 6 months
* Participants that are unwilling to refrain from caffeine, nicotine, and alcohol intake for 12 hours prior to each study visit.
* Known sensitivity to any ingredient in the test formulations as listed in the Nutrition Facts label.
* Individuals who are determined to be on a ketogenic diet.
* Individuals who are cognitively impaired and/or who are unable to give informed consent.
* Participants that are unwilling to refrain from taking biotin at a minimum of 72 hours before visit 3 through the end of the study due to potential interference with laboratory analyses.
* Individuals taking a medication known to impact digestive function or hormonal functions that may impact how our body digests, absorbs or metabolizes nutrients
* Individuals that are currently taking a probiotic or a dietary supplement that may impact digestive function or hormonal function that may impact how our body digests, absorbs or metabolizes nutrients
* Participants that are unwilling to refrain from fermented foods and yogurt, as well as maintain normal consumption levels of prebiotics throughout the study.
* Pregnant women, women trying to become pregnant, or nursing women.
* Individuals who indicate they are actively restricting calories or attempting to lose weight.
* Participants that are unwilling to keep their self-directed training protocols the same throughout the course of the study
* Participants that are unwilling to wear the same shoes and similar clothing for all testing visits.
* Individuals who participate in aerobic exercise \< 2 days/week or have been aerobically training \< 3 years
* Individuals that do not meet the criteria to be defined as well-trained
* Unwillingness to intake a supplement or follow the study protocol
* Any other condition which in the investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose a significant risk to the subject.
Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lindenwood University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chad M Kerksick, PhD

Role: PRINCIPAL_INVESTIGATOR

Lindenwood University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Exercise and Performance Nutrition Laboratory

Saint Charles, Missouri, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-23-71

Identifier Type: -

Identifier Source: org_study_id